Dan Meng

Title: Dan Meng: Innovator in Antibody Development

Introduction

Dan Meng is a prominent inventor based in Jiangsu, China, known for his significant contributions to the field of biotechnology. He holds three patents that focus on innovative antibody therapies aimed at treating immune dysfunction diseases. His work has the potential to impact the medical community significantly.

Latest Patents

Dan Meng's latest patents include the development of an Anti-IL-17A antibody and its applications. This invention provides an antibody or a functional fragment that specifically binds to IL-17A with high affinity. It also includes a nucleic acid molecule encoding the antibody, an expression vector, and a host cell for expressing the antibody. Furthermore, it outlines a method for preparing the antibody and a pharmaceutical composition for treating immune dysfunction diseases. Another notable patent is the Anti-PD-L1 antibody, which also binds with high affinity to PD-L1. This patent includes a nucleic acid molecule encoding the antibody, an expression vector, and a method for producing the antibody. It aims to enhance T cell function to up-regulate cell-mediated immune responses, addressing diseases caused by T cell dysfunction.

Career Highlights

Dan Meng has worked with notable companies in the biotechnology sector, including Suzhou Junmeng Biosciences Co., Ltd. and Shanghai Junshi Biosciences Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas in antibody therapies.

Collaborations

Dan has collaborated with several professionals in his field, including Jian Yao and Hui Feng, who is a woman. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Dan Meng is a key figure in the development of innovative antibody therapies, with patents that hold promise for treating immune dysfunction diseases. His work exemplifies the impact of biotechnology on modern medicine.